West Branch Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.19M Buy
7,358
+1,178
+19% +$358K 0.74% 35
2026
Q1
$1.32M Buy
6,180
+5,908
+2,172% +$1.32M 0.35% 47
2025
Q4
$46.6K Buy
272
+262
+2,620% +$40.7K 0.01% 144
2025
Q3
$1.34K Hold
10
﹤0.01% 368
2025
Q2
$974 Hold
10
﹤0.01% 394
2025
Q1
$727 Hold
10
﹤0.01% 426
2024
Q4
$723 Sell
10
-680
-99% -$51.6K ﹤0.01% 413
2024
Q3
$56.3K Buy
+690
New +$60K 0.02% 153
2018
Q2
Sell
-17,390
Closed -$353K 95
2018
Q1
$353K Buy
+17,390
New +$344K 0.39% 48

Other funds holding LRCX

West Branch Capital's LRCX Position: Q2 2026 in Review

West Branch Capital increased its Lam Research (LRCX) stake by 19% in Q2 2026, buying an estimated $358K and bringing the position to 7,358 shares worth $3.19M. The position accounts for 0.74% of the portfolio, ranked #35.

West Branch Capital first reported a position in LRCX in Q1 2018 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • West Branch Capital held 7,358 shares of Lam Research worth $3.19M as of Q2 2026.
  • West Branch Capital bought 1,178 Lam Research shares in Q2 2026, an estimated $358K.
  • Lam Research made up 0.74% of West Branch Capital's portfolio in Q2 2026, its #35 holding.
  • West Branch Capital first reported a position in Lam Research in Q1 2018 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.